A large scale clinical study demonstrates that achieving a serum urate level below 6 mg per deciliter through properly dosed gout medication significantly lowers the risk of cardiovascular events.
Most Recent Articles
Brain-Derived Tau as a Quantitative Biomarker for Ischemic Stroke Progression and Recovery
A new blood test for brain-derived tau allows clinicians to continuously monitor brain injury progression and predict long-term recovery in stroke patients more effectively than traditional imaging scans
Early Detection Markers for Pancreatic Cancer in Hereditary Chronic Pancreatitis Patients
A humanized mouse model reveals how hereditary chronic pancreatitis triggers a novel inflammatory cell population that cooperates with Kras mutations to accelerate the development of pancreatic cancer.
Biomarker Potential of Circulating Extracellular Vesicles for Heart Failure Risk in Renal Patients
New research identifies renal-produced extracellular vesicles as the specific toxic messengers causing heart failure and high cardiovascular mortality rates in patients with chronic kidney disease.
Metformin and Walking Performance in Non-Diabetic Peripheral Artery Disease: A Randomized Clinical Trial
A multi-center randomized clinical trial published in JAMA reveals that metformin fails to improve walking performance or mobility in non-diabetic patients suffering from peripheral artery disease
